HEXB Inhibitors
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
(Z)-Pugnac | 132489-69-1 | sc-204415A sc-204415 | 5 mg 10 mg | $224.00 $380.00 | 3 | |
(Z)-Pugnac, as a hexose-based acid halide, showcases unique reactivity through its electrophilic carbonyl group, which readily participates in nucleophilic acyl substitution reactions. This compound exhibits a distinct preference for interacting with primary amines, leading to the formation of stable amides. Its structural configuration allows for enhanced steric accessibility, influencing reaction kinetics and selectivity. Additionally, the presence of halogen atoms contributes to its reactivity profile, facilitating diverse synthetic pathways. | ||||||
Galacto-PUGNAc | 1145878-98-3 | sc-489532 sc-489532A | 0.5 mg 5 mg | $679.00 $5304.00 | ||
Galacto-PUGNAc, a hexose-derived acid halide, features a highly reactive carbonyl moiety that engages in selective nucleophilic attacks, particularly with hydroxyl groups. This compound's unique stereochemistry enhances its ability to form cyclic intermediates, influencing reaction dynamics. The halogen substituents not only increase electrophilicity but also modulate steric hindrance, allowing for tailored reactivity in complex synthetic routes. Its solubility characteristics further facilitate interactions in various solvent systems. | ||||||
Pyrimethamine | 58-14-0 | sc-208190 sc-208190A sc-208190B | 1 g 5 g 25 g | $80.00 $238.00 $825.00 | 5 | |
Dihydrofolate reductase inhibitor; can indirectly affect HEXB by altering cellular metabolism and lysosomal function. | ||||||
Conduritol B Epoxide (CBE) | 6090-95-5 | sc-201356 sc-201356A sc-201356B sc-201356C sc-201356D sc-201356E sc-201356F | 5 mg 25 mg 50 mg 100 mg 250 mg 1 g 5 g | $79.00 $320.00 $500.00 $614.00 $1311.00 $5212.00 $20818.00 | 12 | |
Inhibitor of beta-glucosidase; can potentially influence HEXB by affecting related glycosidase activities. | ||||||
Nojirimycin-1-Sulfonic Acid | 114417-84-4 | sc-208102 | 10 mg | $420.00 | ||
Glycosidase inhibitor; might indirectly affect HEXB by inhibiting related glycosidases. | ||||||
Castanospermine | 79831-76-8 | sc-201358 sc-201358A | 100 mg 500 mg | $184.00 $632.00 | 10 | |
Glycosidase inhibitor; can affect HEXB indirectly by modulating glycosidase activities. | ||||||
Swainsonine | 72741-87-8 | sc-201362 sc-201362C sc-201362A sc-201362D sc-201362B | 1 mg 2 mg 5 mg 10 mg 25 mg | $138.00 $251.00 $631.00 $815.00 $1832.00 | 6 | |
Inhibitor of alpha-mannosidase; potentially influences HEXB by affecting glycoside processing pathways. | ||||||
Deoxynojirimycin | 19130-96-2 | sc-201369 sc-201369A | 1 mg 5 mg | $73.00 $145.00 | ||
Alpha-mannosidase inhibitor; might impact HEXB indirectly by influencing glycoprotein processing. | ||||||
Genistein | 446-72-0 | sc-3515 sc-3515A sc-3515B sc-3515C sc-3515D sc-3515E sc-3515F | 100 mg 500 mg 1 g 5 g 10 g 25 g 100 g | $45.00 $164.00 $200.00 $402.00 $575.00 $981.00 $2031.00 | 46 | |
Tyrosine kinase inhibitor; can indirectly affect HEXB by modulating cell signaling pathways. | ||||||
Cyclophosphamide | 50-18-0 | sc-361165 sc-361165A sc-361165B sc-361165C | 50 mg 100 mg 500 mg 1 g | $90.00 $146.00 $469.00 $791.00 | 18 | |
Alkylating agent; potentially affects HEXB through broader impacts on cellular metabolism and stress responses. | ||||||